'Big data' analysis reveals new targets for treating ovarian cancer
A recent study used a big data multi-omics analysis to examine changes in gene expression as cells from human fallopian tubes become cancerous.
Jan 12, 2024
0
2
A recent study used a big data multi-omics analysis to examine changes in gene expression as cells from human fallopian tubes become cancerous.
Jan 12, 2024
0
2
A new 225Ac-DOTA-based pre-targeted radioimmunotherapy (PRIT) system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects. Targeting the ...
Sep 18, 2023
0
23
Mayo Clinic scientists are shining light on ovarian cancer. A study published in 2022 in the Journal of Clinical Oncology explored the use of fluorescence-guided surgery to treat epithelial ovarian cancer, the most common ...
Aug 31, 2023
0
1
A new editorial paper was published in Oncoscience, titled, "UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?"
May 26, 2023
0
3
Two new discoveries led by Cedars-Sinai Cancer investigators help improve the understanding of what drives the development of ovarian cancer and why some women's tumors do not respond to therapy.
Oct 10, 2022
0
159
Epithelial ovarian cancer (EOC) exhibits strong dependency on the tricarboxylic acid (TCA) cycle and oxidative phosphorylation to fuel anabolic process. S-palmitoylation refers to the addition of the saturated 16-carbon fatty ...
Jun 10, 2022
0
1
The fallopian tube is the site of fertilization, where once a month for the duration of a female's post-pubescent, pre-menopausal life, an egg is moved from the ovary, ready for fertilization by a sperm cell.
Mar 22, 2022
0
12
University of Queensland researchers have demonstrated a genetic link between endometriosis and ovarian cancer subtypes enabling them to identify potential drug targets for therapy and increasing the understanding of both ...
Mar 15, 2022
0
67
Epithelial ovarian cancer (EOC) is the most common lethal gynecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments ...
May 27, 2021
0
1
The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the "Oxford Classic," researchers have demonstrated ...
Jan 14, 2021
0
13